A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2004
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472233A1 Pyrimidine compounds
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471881A2 Use of a compound inactivating the kinase a protein in a composition containing a cosmetically acceptable medium in order to lighten the skin
11/03/2004	EP1471879A1 Topical glycopyrrolate product
11/03/2004	EP1471876A1 Method of enhancing hair growth
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1435906A4 Method for producing biologically active products
11/03/2004	EP1404315B1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004	EP1317425B1 Resorcinol derivatives
11/03/2004	EP1250331B1 Formulation for protection against oxidative stress containing benzofuranone derivatives
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1173273B1 Novel stable water-in-oil emulsions containing an emulsifier based on oleyl- and/or isostearyl-glycoside
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	CN1543503A Metalloproteinase inhibitors for wound healing
11/03/2004	CN1543466A New use of specific cyclolignans
11/03/2004	CN1543462A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004	CN1543354A Botulinum toxin in the treatment or prevention of acne
11/03/2004	CN1543338A Chitin microparticles and their medical uses
11/03/2004	CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004	CN1541702A Externally applied traditional drug prescription for removing flat wart and its preparation
11/03/2004	CN1541698A Prepared traditional medicine applied in tumor surgical operation, radiotheraphy and chemotherapy
11/03/2004	CN1541667A Active enzyme biological medicinal composition
11/03/2004	CN1541666A Chinese traditional medicine composition for treating bedsore and acute soft tissue injury
11/03/2004	CN1541656A Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
11/03/2004	CN1174037C Gel composition
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004	CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
11/03/2004	CN1173732C Traditional Chinese medicine pills for skin and venereal disease and urinary system infection
11/03/2004	CN1173729C Aloe product and its preparing method
11/03/2004	CN1173721C External-use ointment
11/03/2004	CN1173703C Pharmaceutical composition
11/03/2004	CN1173697C Aniline disulfide derivatives for treating allergic diseases
11/03/2004	CN1173692C Cosmetic composition and method for reducing skin aging procedure
11/03/2004	CN1173685C Cosmetic compositions for the prevention and therapy of hair loss
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812236 Compounds useful in therapy
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812220 Pharmaceutical compositions and methods relating to fucans
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
11/02/2004	US6811796 Administering plant extracts; health food
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	CA2283676C Stimulation, culture and preservation of pancreatic and other cells
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/02/2004	CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092180A1 Flavone derivatives, process for producing them, and drugs containing the same
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092163A1 Phenylazole compound, production process, and antioxidant drug
10/28/2004	WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
10/28/2004	WO2004092118A2 2-propylidene-19-nor-vitamin d compounds
10/28/2004	WO2004091646A2 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction
10/28/2004	WO2004091640A1 Skin protecting compositions
10/28/2004	WO2004091639A2 Lipid extract from fruit of low lipid content
10/28/2004	WO2004091638A1 Herbal composition
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004091595A1 Use of alkyl resorcinols in the treatment of acne
10/28/2004	WO2004091558A2 Compounds for stimulating and for inhibiting melanin formation, and methods for screening these compounds
10/28/2004	WO2004091474A2 Methods for the preparation of dhea derivatives
10/28/2004	WO2004082583A3 Use of oligogalacturonides in cosmetics or for the preparation of a dermatological or pharmaceutical composition
10/28/2004	WO2004075867A3 Preparations containing an extract of eperua falcata and/or constituents of the latter
10/28/2004	WO2004073731A8 14-3-3 protein for prevention and treatment of fibroproliferative disorders
10/28/2004	WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders
10/28/2004	WO2004056827A3 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
10/28/2004	WO2004043481A3 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003077840A3 Method of modulating inflammatory response
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004	US20040214864 Novel compounds
10/28/2004	US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens
10/28/2004	US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors

1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 1065